"Mushroom Supplements: Separating Fact from Fiction"
The popularity of mushroom-based products has surged in recent years, with the functional mushroom market valued at nearly $26.7 billion in 2021 and expected to grow to $65.8 billion by 2030. While promising research suggests health benefits such as immune support and tumor suppression from mushrooms like reishi, shiitake, chaga, lion’s mane, and turkey tail, experts caution that existing research is limited and more long-term clinical trials are needed. The distribution of mushroom supplements remains largely unregulated, and while they appear to be harmless at worst, some studies have shown potential for causing auto-immune flare-ups and toxicity. As the "shroom boom" continues, the debate over the medicinal properties of mushrooms persists, with the need for more rigorous research and regulation in the industry.
